Vaccines

 
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 30, 2022
June 30, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

FDA Recommends COVID-19 Booster Doses Optimized for Omicron Variant
June 30, 2022

The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 28, 2022
June 28, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 27, 2022
June 27, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 23, 2022
June 23, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 22, 2022
June 22, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Merck & Co 21-valent Pneumococcal Conjugate Vaccine Ready for Phase III
June 22, 2022

The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 21, 2022
June 21, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 17, 2022
June 17, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children 6 Months and Up
June 17, 2022

The FDA authorized emergency use of Moderna and Pfizer-BioNTech's COVID-19 vaccines for use in children as young as 6 months old.